Investor
News & Events
Financial Reports
Stock Information
Corporate Governance
Contacts & Alerts
Press Releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Apr 13, 2020Danaher Corporation (NYSE: DHR) ("Danaher" or "the Company") announced today that for the quarter ended April 3, 2020 it expects revenue growth of approximately 3.0% and non-GAAP core revenue...
-
Apr 3, 2020
Danaher Corporation (NYSE: DHR) ("Danaher") announced today that it has priced a reopening of: €150,000,000 principal amount of additional 1.700% senior notes due 2024 at an offering price of...
-
Mar 31, 2020
Danaher Corporation (NYSE: DHR) ("Danaher") announced today the completion of its acquisition of the Biopharma business from General Electric Company's (NYSE: GE) Life Sciences division. As part...
-
Mar 25, 2020
Danaher Corporation (NYSE: DHR) ("Danaher") announced today that it has priced an offering of: €750,000,000 principal amount of 1.700% senior notes due 2024 at an offering price of 99.931% of...
-
Mar 19, 2020
Danaher Corporation (NYSE: DHR) ("Danaher") announced today that the U.S. Federal Trade Commission (the "FTC") has accepted the proposed consent order in connection with Danaher's definitive...